Test Bank for Rau’s Respiratory Care Pharmacology 9th Edition Gardenhire Study Questions With Answers

TEST BANK |




RAU’s Respiratory Care Pharmacology
| | |




9TH EDITION|




BY GARDENHIRE
|




TEST BANK |

,Description
Test Bank for Rau’s Respiratory Care Pharmacology 9th Edition Gardenhire


Test Bank for Rau’s Respiratory Care Pharmacology, 9th Edition, Gardenhire, ISBN-10:
0323299687, ISBN-13: 9780323299688




Table |of |Contents


Unit |I: |Basic |Concepts |and |Principles |in |Pharmacology
1. |Introduction |to |Respiratory |Care |Pharmacology
2. |Principles |of |Drug |Action
3. |Administration |of |Aerosolized |Agents
4. |Calculating |Drug |Doses
5. |The |Central |and |Peripheral |Nervous |Systems


Unit |II: |Drugs |Used |to |Treat |the |Respiratory |System
6. |Adrenergic |(Sympathomimetic) |Bronchodilators
7. |Anticholinergic |(Parasympatholytic) |Bronchodilators
8. |Xanthines
9. |Mucus-Controlling |Drug |Therapy
10. |Surfactant |Agents
11. |Corticosteriods |in |Respiratory |Care
12. |Nonsteroidal |Antiasthma |Agents
13. |Aerosolized |Antiinfective |Agents
14. |Antimicrobial |Agents
15. |Cold |and |Cough |Agents
16. |Selected |Agents |of |Pulmonary |Value
17. |Neonatal |and |Pediatric |Aerosolized |Drug |Therapy


Unit |III: |Critical |Care, |Cardiovascular, |and |Polysomnography |Agents
18. |Skeletal |Muscle |Relaxants |(Neuromuscular |Blocking |Agents)
19. |Diuretic |Agents
20. |Drugs |Affecting |the |Central |Nervous |System
21. |Vasopressors, |Inotropes, |and |Antiarrythmic |Agents
22. |Drugs |Affecting |Circulation: |Antihypertensives, |Antianginals, |Antithrombotics
23. |Sleep |and |Sleep |Pharmacology

,Chapter 01: Introduction to Respiratory Care Pharmacology Gardenhire:
| | | | | | |



Rau’s Respiratory Care Pharmacology, 9th Edition
| | | | | |




MULTIPLE |CHOICE

1. What |is |the |name |of |the |receptor |sites |that |are |located |in |the |peripheral |vasculature, |the |heart, |bronchial
|muscle, |and |bronchial |blood |vessels?

a. Beta |2 |receptors c. Alpha |receptors
b. Gamma |receptors d. | | Beta |1 |receptors
ANS: | C
Alpha |receptors |are |located |in |the |peripheral |vasculature, |the |heart, |bronchial |muscle, |and |bronchial
|blood |vessels.




PTS: | 1

2. Which |receptor |site |results |in |tachycardia, |an |increased |potential |for |arrhythmias, |and |an |increased
|cardiac |output?

a. Beta |1 |receptor c. Alpha |receptor
b. Beta |2 |receptor d. | Delta |receptor
ANS: | A
Stimulation |of |the |beta-1 |receptors |results |in |tachycardia, |an |increased |potential |for |arrhythmias, |and |an
|increased |cardiac |output. |In |administering |drugs |to |the |pulmonary |system, |stimulation |of |the |beta-1 |sites


|is |not |desired. |However, |most |respiratory |pharmacologic |agents |have |some |beta-1 |stimulatory |effect.




PTS: | 1

3. Stimulation |of |the |beta |2 |receptors |causes |
a. peripheral |vasoconstriction |and |mild |bronchoconstriction |in |the |lungs.
b. tachycardia, |an |increased |potential |for |arrhythmias, |and |an |increased |cardiac |output.
c. bronchodilation.
d. peripheral |vasodilation, |bradycardia, |and |decreased |cardiac |output.
ANS: | C
Stimulation |of |the |beta-2 |receptors |in |the |lungs |causes |bronchodilation.

PTS: | 1

4. Acetylcholine |stimulates |
a. the |Vagus |nerve.
b. the |adrenergic |receptors.
c. the |sympathetic |nervous |system.
d. the |cholinergic |receptors.
ANS: | D
Acetylcholine |stimulates |the |cholinergic |receptors.

PTS: | 1

5. What |immunoglobulin |antibody |sensitizes |the |mast |cell?
a. Leukotrienes c. Histamine

, b. IgE d. | Prostaglandins
ANS: | B
The |IgE |(reagin) |antibodies |sensitize |the |mast |cell. |Repeated |exposure |to |the |antigen |causes |the
|degranulation |of |the |mast |cell.




PTS: | 1

6. Which |of |the |following |is |caused |by |histamine |release |from |the |mast |cells?
I. Bronchodilation
II. Increased |bronchial |gland |secretion
III. Increased |amount |of |mucus |present |in |the |airways
a. I |and |II |only c. III |only
b. II |and |III |only d. | | I, |II, |III
ANS: | B
Histamine |is |also |a |potent |bronchoconstrictor. |In |addition |to |its |bronchoconstrictive |activity, |histamine
II) |increases |bronchial |gland |secretion, |causing |III) |an |increase |in |the |amount |of |mucus |present |in
|the |airways. |Histamine |may |also |have |an |effect |on |vascular |permeability |similar |to |the |effect |of-


|SRS-A.




PTS: | 1

7. A |sympathomimetic |drug |would |cause |
a. bronchodilation. c. Histamine |release.
b. bronchoconstriction. d. | Vagus |nerve |stimulation.
ANS: | A
A |sympathomimetic |drug |would |cause |bronchodilation. |Sympathomimetic |agents |are |the |drugs |most |commonly
|used |to |reverse |bronchospasm.




PTS: | 1

8. Stimulation |of |the |sympathetic |nervous |system |causes |
a. vascular |permeability. c. bronchodilation.
b. decreased |blood |pressure. d. | bronchoconstriction.
ANS: | C
Sympathetic |nervous |system |stimulation |causes |bronchodilation.

PTS: | 1

9. Which |of |the |following |would |NOT |cause |a |bronchospasm |or |bronchoconstriction?
a. Leukotrienes c. Histamine
b. Beta |1 |receptors d. | Prostaglandins
ANS: | B
Beta-1 |receptors |would |not |cause |a |bronchospasm |or |bronchoconstriction. |Leukotrienes |are |one |of
|many |chemical |mediators |released |by |the |mast |cells. |Leukotrienes |cause |a |direct, |strong

|bronchoconstriction. |Histamine |is |also |a |potent |bronchoconstrictor. |Prostaglandins |cause |a |strong

|bronchospasm, |especially |in |asthmatic |patients.



PTS: | 1